Trial Profile
A phase III multiple-dose, randomized, double-blind, parallel study comparing TX01 with Neupogen in healthy volunteers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2018
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Filgrastim
- Indications Neutropenia
- Focus Pharmacodynamics
- 23 Feb 2018 New trial record